70370-3050 : Ongentys 50 mg Oral Capsule
| NDC: | 70370-3050 |
| Labeler: | Neurocrine Biosciences, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Ongentys |
| Dosage Form: | Oral Capsule |
| Application #: | NDA212489 |
| Rev. Date: |
Appearance:
| Markings: | OPC;50 |
| Shapes: |
Oval |
| Colors: |
 Blue |
| Size (mm): | 19 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 70370-3050-2: 30 CAPSULE IN 1 BOTTLE (70370‑3050‑2)
- 70370-3050-5: 7 CAPSULE IN 1 BOTTLE (70370‑3050‑5)
Active Ingredients:
- Opicapone
Dosage Strength:
- 50 mg
Inactive Ingredients:
- Starch, Corn
- Lactose, Unspecified Form
- Sodium Starch Glycolate Type a Potato
- Magnesium Stearate
- Gelatin
- Titanium Dioxide
- Fd&c Red No. 3
- Fd&c Blue No. 2 /
Pharmaceutical Classes:
- Catechol O-Methyltransferase Inhibitors [MoA]
- Catechol-O-Methyltransferase Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 70370-3025 Ongentys 25 mg Oral Capsule by Neurocrine Biosciences, Inc.
- 64896-402 Ongentys 25 mg Oral Capsule by Amneal Pharmaceuticals LLC
- 64896-403 Ongentys 50 mg Oral Capsule by Amneal Pharmaceuticals LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70370-3025Next: 70370-4040 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.